NEW YORK, Sept. 29, 2023 /PRNewswire/ — The hunting equipment market in Americas is estimated to grow by USD 733.75 million from 2022 to 2027, growing at a CAGR of 1.47%. The hunting equipment market in Americas is fragmented owing to the presence of many global and regional companies. A…
Month: September 2023
DUBLIN, Sept. 29, 2023 /PRNewswire/ — The “Patient Centric Healthcare App Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The report offers in-depth insights into the fast-evolving…
220 BASIS Charter School students earned the prestigious honors. BASIS is celebrating each of them. SCOTTSDALE, Ariz. and SAN ANTONIO, Texas, Sept. 29, 2023 /PRNewswire/ — We are proud to share that more than 200 students from 13 BASIS Charter School campuses have received recognition…
DUBLIN, Sept. 29, 2023 /PRNewswire/ — The “Building Integrated Photovoltaics (BiPV) – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global Building Integrated Photovoltaics (BiPV) market is poised for remarkable expansion, with…
NEW YORK, Sept. 29, 2023 /PRNewswire/ — The “wearables market in US by distribution channel (online and offline) – Forecast and Analysis 2023-2027” report has been added to the technavio offering. With ISO 9001:2015 certification, Technavio has proudly partnered with more than 100…
SILVER SPRING, Md., Sept. 29, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration granted de novo marketing authorization for the Invitae Common Hereditary Cancers Panel, an in vitro diagnostic test that can help detect hundreds of genetic variants associated with an…
BEIJING, Sept. 29, 2023 /PRNewswire/ — On June 30, 2023, WeTrade Group Inc. (the “Company”)(NASDAQ: WETG) received the resignation letters of directors Biming Guo, Ning Qin, Yuxin Ye, Grace Li, CEO Hechun Wei, and CFO Annie Huang (the “Former Directors and Officers”). On September 22,…
NEW YORK, Sept. 29, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Design Therapeutics, Inc. (“Design” or the “Company”) (NASDAQ: DSGN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, Sept. 29, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Tremor International Ltd. (“Tremor” or the “Company”) (NASDAQ: TRMR). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, Sept. 29, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of The Lovesac Company (“Lovesac” or the “Company”) (NASDAQ: LOVE). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
